Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Common Cents Systems and Translational Software Improve Efficiency in Pharmacogenetic Testing

Published: Tuesday, February 04, 2014
Last Updated: Tuesday, February 04, 2014
Bookmark and Share
The collaboration combines Apollo’s platform for operational excellence with Translational Software’s PGx decision support system.

Common Cents Systems, Inc.(ApolloLIMS) and Translational Software have successfully collaborated to improve Pharmacogenetic (PGx) testing and reporting processes. This strategic collaboration combines Apollo’s platform for operational excellence with Translational Software’s PGx decision support system to enable their customers to improve turnaround time, decrease errors, and make test results more relevant for clinicians.

There is a rapid adoption of pharmacogenetic testing in laboratories across the nation as clinicians recognize the value of genetic testing. As a result, laboratories are producing large amounts of complex genetic data. To interpret the genetic data into actionable medical information a pharmacogenetic knowledgebase is needed. Typically a clinical laboratory does not have the dedicated resources available to develop a knowledgebase or the IT resources to link the laboratory and knowledgebase together.

The ApolloLIMS Lab Automation component gives the lab automated programmatic processes that intelligently send and receive data directly with the laboratory testing equipment without requiring data entry by the operator.  By combining that with the Apollo eXchange HL7 Interface engine, the companies have been successful in creating a bi-directional seamless integration from the pre-analytic, analytic, and post-analytic phases.  The interface with the Translational Knowledgebase adds the interpretive phase and highly configurable report designs to the integration. Many laboratories have already seen the benefits of this collaboration in terms of elimination of duplicate data entry, streamlined work flow resulting in decreased turnaround time and improved customer satisfaction.

Rob Ringenberg, president of Common Cents Systems, Inc., sees the value that can be delivered to customers through the collaboration.  "Laboratory automation is key to efficiency in the modern laboratory.  ApolloLIMS excels at delivering a high level of automation through instrument interfaces, foreign system interfaces and web products.  By working directly with the senior staff at Translational Software we have been able to greatly reduce the project timeline and deliver a superior end product.”

Until recently, clinical adoption of genomic testing has been inhibited by the massive amounts of data, challenging analysis, and the difficulty of adapting research technologies to the clinical setting. Don Rule, Translational’s founder and CEO, says “we recognized that there was an opportunity to augment current solutions that required knowledge of genetics, pharmacology, and informatics. By combining these skill sets we’ve developed a system that enables diagnostic laboratories to bring pharmacogenetic testing to the market dramatically faster.”
This alliance marries a laboratory's need for intelligent software (like ApolloLIMS) and the extensive pharmacogenetic clinical decision support that Translational Software has to offer. A strategic partnership like this one could not have come at a better time for the laboratory world and the Return on Investment (ROI) by early adopters has already proven it to be successful.




Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Genetic Tug of War
Researchers have reported on a version of genetic parental control in mice that is more targeted, and subtle than canonical imprinting.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Researchers Resurrect Ancient Viruses
Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina.
Cell Aging Slowed by Putting Brakes on Noisy Transcription
Experiments in yeast hint at ways to extend life of some human cells.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!